Immunofluorescence Labeling Indices in Myeloma and Related Monoclonal Gammopathies
Authors:
- Thomas E. WitzigTWThomas E. Witzig
- Nick J. GonchoroffNGNick J. Gonchoroff
- Thomas M. HabermannTHThomas M. Habermann
- Jerry A. KatzmannJKJerry A. Katzmann
- W. Michael O'FallonWOW. Michael O'Fallon
- Robert A. KyleRKRobert A. Kyle
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 62 (11) , 969-977
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- S-phase detection with an antibody to bromodeoxyuridineJournal of Immunological Methods, 1986
- A monoclonal antibody reactive with a subset of human plasma cellsBritish Journal of Haematology, 1986
- A monoclonal antibody reactive with 5‐bromo‐2‐deoxyuridine that does not require DNA denaturationCytometry, 1985
- Pre-B cells in peripheral blood of multiple myeloma patientsBlood, 1985
- Multiple myeloma: significance of plasmablastic subtype in morphological classificationBlood, 1985
- Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapyBritish Journal of Haematology, 1984
- Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myelomaBlood, 1983
- Ploidy and proliferative characteristics in monoclonal gammopathiesBlood, 1982
- Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.Journal of Clinical Investigation, 1981
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980